Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Women'S Health (London, England)|July 10, 2009
Paget's disease of the nippleSeema Seetharam, Ian S FentimanPharmaceuticals (Basel, Switzerland)|October 8, 2016
The Role of Non-Steroidal Anti-Inflammatory Drugs in the Chemoprevention of Breast CancerSarah L Horn, Ian S FentimanLancet (London, England)|February 21, 2006
Male breast cancerIan S Fentiman, Alain Fourquet, Gabriel N HortobagyiBreast Care (Basel, Switzerland)|December 7, 2016
The Role of NSAIDs in Breast Cancer Prevention and Relapse: Current Evidence and Future PerspectivesDemetrios Moris, Michalis Kontos, Eleftherios Spartalis, et al.Journal of the National Cancer Institute|March 18, 2004
Melatonin and breast cancer: a prospective studyRuth C Travis, Diane S Allen, Ian S Fentiman, et al.European Journal of Cancer (Oxford, England : 1990)|June 11, 2011
Risk factors for metachronous contralateral breast cancer suggest two aetiological pathwaysVoralak Vichapat, Cheryl Gillett, Ian S Fentiman, et al.Cancer Treatment Reviews|May 16, 2006
Insight into the treatment of cancer in older patients: developments in the last decadeDaniele Bernardi, Domenico Errante, Umberto Tirelli, et al.Lancet (London, England)|July 18, 2003
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trialJoan Houghton, W D George, Jack Cuzick, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 3, 2004
Caesium(137) implant as sole radiation therapy for operable breast cancer: a phase II trialIan S Fentiman, Vinay Deshmane, David Tong, et al.Breast Cancer Research and Treatment|June 15, 2011
Prognosis of metachronous contralateral breast cancer: importance of stage, age and interval time between the two diagnosesVoralak Vichapat, Hans Garmo, Lars Holmberg, et al.Pageof 6